A suboptimal in utero environment leads to fetal adaptations to ensure short-term survival but in the long-term may lead to disease when the postnatal growth does not reflect that in utero. This study examined the effect of IUGR on whole body insulin sensitivity and metabolic activity in adult rats. Female Wistar-Kyoto rats were fed either a normal protein diet (NPD 20% casein) or a low protein diet (LPD; 8.7% casein) during pregnancy and 2 wk of lactation. In offspring at 32 wk of age, indirect calorimetry and dual energy x-ray absorptiometry (DEXA) were performed to assess metabolic activity and body composition. Insulin sensitivity was assessed using a euglycemic-hyperinsulinemic clamp. At 3 d of age, male and female LPD offspring were 23 and 27% smaller than controls, respectively. They remained significantly smaller throughout the experimental period (ϳ10% smaller at 32 wk). Importantly, there was increased insulin sensitivity in LPD offspring (47% increase in males and 38% increase in females); pancreatic insulin content was normal. Body composition, O 2 consumption, respiratory exchange ratio (RER), and locomotor activity were not different to controls. These findings suggest that in the absence of "catch-up" growth IUGR programs for improved insulin sensitivity. O ver recent years, there has been an escalation in the incidence of metabolic syndrome and type 2 diabetes within the community, and this has been linked to a mismatch in prenatal and postnatal growth (1-3). In this regard, many epidemiological and experimental studies support the hypothesis that a suboptimal in utero environment leads to fetal adaptations to ensure short-term survival but, in turn, lead to long-term disease risk when the postnatal environment does not reflect that in utero (2-4). In addition, IUGR leads to a reduction in prenatal growth and altered ontogeny of major organs, which may also contribute to long-term disease risk (5-8). For example, IUGR, because of maternal protein restriction in rats has been shown to lead to a reduced number of cardiomyocytes in the heart (6), reduced nephron endowment in the kidney (7), and reduced -cell proliferation and islet size in the pancreas (8).Hence, it is likely that altered programming of glucose metabolism coupled with direct reductions in pancreatic islet  cells contribute to the development of metabolic syndrome and type 2 diabetes in infants that were growth restricted in utero, particularly when the postnatal growth trajectory is inappropriately higher than that in utero (9). Although there is substantial evidence to support this hypothesis, whether IUGR can program for improved postnatal glucose metabolism in the absence of "catch-up" growth has been relatively unexplored, and it is imperative that this alternative be rigorously tested. Importantly, in this regard, in our laboratory, we have a model of maternal protein restriction in Wistar Kyoto (WKY) rats where the IUGR offspring remain smaller throughout life when compared with nongrowth restricted offspring; thes...